Critical Insights From Roivant Sciences Analyst Ratings: What You Need To Know
Critical Insights From Roivant Sciences Analyst Ratings: What You Need To Know
来自Roivant Sciences分析师评级的关键见解：你需要知道的
7 analysts have expressed a variety of opinions on Roivant Sciences (NASDAQ:ROIV) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，有7位分析师对Roivant Sciences（纳斯达克股票代码：ROIV）表达了各种观点，从看涨到看跌，提出了各种各样的观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $18.0, with a high estimate of $23.00 and a low estimate of $15.00. Marking an increase of 10.77%, the current average surpasses the previous average price target of $16.25.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为18.0美元，最高估计为23.00美元，低估值为15.00美元。当前的平均价格上涨了10.77％，超过了之前的平均目标股价16.25美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细明细
The analysis of recent analyst...
对分析师最...
登录免费看全文
登录/注册